​

Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Voyager Therapeutics Ownership Summary

Voyager Therapeutics is owned by 28.89% institutional investors, 16.45% insiders, and 54.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.55% of VYGR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics28.89%16.45%54.66%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.62M9.55%$22.08M
Blackrock5.31M9.30%$42.02M
Armistice capital4.20M7.16%$19.61M
Vanguard group3.27M5.55%$12.84M
Vestal point capital, lp1.48M2.51%$6.89M
Erste asset management gmbh1.20M2.03%$4.72M
Geode capital management1.14M1.93%$4.46M
Dimensional fund advisors lp1.08M1.84%$4.26M
State street925.36K1.58%$4.32M
Ecor1 capital670.30K1.14%$3.13M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Birchview capital, lp134.92K0.48%$630.07K
Vestal point capital, lp1.48M0.31%$6.89M
Armistice capital4.20M0.29%$19.61M
Sphera funds management199.76K0.20%$932.88K
Ecor1 capital670.30K0.15%$3.13M
Clarivest asset management102.82K0.08%$813.32K
Virtus fund advisers4.03K0.07%$22.85K
Privium fund management b.v.95.00K0.07%$373.35K
Caitong asset management5.94K0.06%$23.36K
Patriot financial group insurance agency102.72K0.05%$403.67K

Top Buyers

HolderShares% AssetsChange
Blackrock5.31M0.00%915.17K
Bank of america corp /de/648.76K0.00%294.32K
Sphera funds management199.76K0.20%199.76K
Two sigma investments, lp140.72K0.00%140.72K
Birchview capital, lp134.92K0.48%134.92K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital670.30K0.15%-3.25M
Farallon capital management---715.00K
Great point partners---626.27K
Armistice capital4.20M0.29%-600.00K
Prudential financial---330.30K

New Positions

HolderShares% AssetsChangeValue
Sphera funds management199.76K0.20%199.76K$932.88K
Two sigma investments, lp140.72K0.00%140.72K$657.14K
Birchview capital, lp134.92K0.48%134.92K$630.07K
Two sigma advisers, lp58.60K0.00%58.60K$273.66K
Cubist systematic strategies44.56K0.00%44.56K$208.09K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-16.00
Richards, merrill & peterson-30.00
Rothschild investment-30.00
Gamma investing-50.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202578-34.45%16,989,289-43.76%281.09%30-43.40%29-25.64%
Sep 30, 2025111-0.89%25,893,441-21.95%441.38%472.17%375.71%
Jun 30, 2025109-6.03%33,129,2617.64%562.03%45-2.17%33-21.43%
Mar 31, 2025116-12.12%34,619,8870.33%591.67%46-32.35%4216.67%
Dec 31, 2024131-0.76%34,504,533-1.80%591.62%6715.52%36-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.71M3.10%-
Vanguard Total Stock Mkt Idx Inv1.67M2.83%-
iShares Russell 2000 ETF1.16M1.96%1.16M
Vanguard Institutional Extnd Mkt Idx Tr485.69K0.82%-
Vanguard Explorer Inv457.06K0.82%-
Fidelity Small Cap Index459.20K0.78%-32.14K
iShares Russell 2000 Value ETF392.70K0.67%392.70K
BlackRock Health Sciences Opps Inv A371.16K0.63%-2.78K
iShares Biotechnology ETF344.09K0.58%-
Federated Hermes MDT SCC Institutional270.35K0.50%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 24, 2026Swartz Robin COO & CBOSell$24.35K
Feb 24, 2026Sandrock Alfred President and CEOSell$53.81K
Feb 24, 2026Jorgensen Nathan D. Chief Financial OfficerSell$17.60K
Feb 24, 2026Carter Todd Alfred Chief Scientific OfficerSell$15.69K
Feb 18, 2026Swartz Robin COO & CBOSell$13.35K

Insider Transactions Trends

DateBuySell
2026 Q1-10
2025 Q4-1
2025 Q3-1
2025 Q2-2
2025 Q1-9

VYGR Ownership FAQ

Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 28.89%, followed by 16.45% insiders and 54.66% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 382.13%, which Voyager Therapeutics falls below.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.62M shares, 9.55%), Blackrock (5.31M shares, 9.30%), and Armistice capital (4.2M shares, 7.16%). Together, they hold 26.02% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Birchview capital, lp is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.48% of its assets in 134.92K Voyager Therapeutics shares, valued at 630.07K$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Voyager Therapeutics shares, with 3.10% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools